drugset
drugset / Trial / NCT00765700

Ketoprofen 10% Cream for Treatment of Pain Associated With Mild to Moderate Acute Soft Tissue Injury

NCT00765700 ↗

Phase 3 Completed 364 enrolled Imprimis Pharmaceuticals, Inc. Cato Research · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Imprimis Pharmaceuticals is investigating a proprietary, topical cream formulation consisting of 10% ketoprofen (containing 100 mg of ketoprofen in 1gram of cream) for the local treatment of acute musculoskeletal pain.

Timeline

Start
2008-09
Primary completion
2009-08
Completion
2009-09

Publications

  • Results E. Ekman, S. Skrepnik, M. Jones , K. Lawson, and J. Schupp. EFFICACY AND SAFETY OF KETOPROFEN 10% CREAM IN ACUTE SOFT TISSUE INJURIES (PHASE 3 STUDY TDLP-110-001). Poster Presentation, Sep. 2, 2010, 13th World Congress on Pain in Montreal, Canada.

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ketoprofen Small molecule 1 g Topical

Indications

No indication recorded.